Abstract: The present invention relates to granulysin, method of obtaining same, and uses, specifically to the granulysin polypeptide for the use thereof as a medicinal product via the systemic route and to a chimeric molecule comprising a recombinant antibody targeting a tumor antigen and the granulysin polypeptide.
Type:
Grant
Filed:
July 24, 2019
Date of Patent:
January 2, 2024
Assignees:
UNIVERSIDAD DE ZARAGOZA, FUNDACIÓN AGENCIA ARAGONESA PARA LA INVESTIGACIÓN Y EL DESARROLLO (ARAID), FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA
Inventors:
Luis Alberto Anel Bernal, Raquel Ibañez Perez, Patricia Guerrero Ochoa, Luis Martinez Lostao, Blanca Conde Guerri, Ramón Hurtado Guerrero, Ana Laura Sanz Alcober, Rocio Navarro Ortiz